• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Pet vaccine revolt; Unclaimed bodies in Texas medical schools; FDA approved generic Vyvanse; - Morning Medical Update


The top news stories in primary care today.

doctor morning desk © Alena Kryazheva -

doctor morning desk © Alena Kryazheva -

Pet vaccine revolt

Over half of dog owners now believe vaccines are unsafe for their pets, which is likely fallout from vaccine hesitancy bred during the pandemic. In addition, almost 40% of dog owners worry vaccines could lead to “canine autism.” The study was conducted by researchers at Boston University. The full study can be found here.

Unclaimed bodies in Texas medical schools

An increasing number of dead bodies are used in Texas medical schools, according to a recent survey. From 2017 to 2021 totals jumped from 64 bodies to 446 bodies. The practice is legal in most counties and states with New York being the exception.

FDA approved generic Vyvanse

The Food and Drug Administration has approved multiple generic forms of attention-deficit/hyperactivity disorder (ADHD) medication Vyvanse. It is approved for patients six years and older and for adults with binge eating disorder (BED). The medication will be available in chewable tablets and capsules.

Related Videos
Jennifer N. Lee, MD, FAAFP
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health